Ghias Babar
SEC insider (Form 3/4/5 filer). CIK 0002076862. CFO & Head of Corp Development at BIOCRYST PHARMACEUTICALS INC (BCRX). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in DURHAM, NC.
Companies Ghias Babar has filed insider reports for
- BIOCRYST PHARMACEUTICALS INC (BCRX): Officer, CFO & Head of Corp Development
Ghias Babar
CIK: 0002076862
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCRX
BIOCRYST PHARMACEUTICALS INC
Officer